These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27983558)

  • 1. Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?
    Squitti R; Mendez AJ; Simonelli I; Ricordi C
    J Alzheimers Dis; 2017; 56(3):1055-1064. PubMed ID: 27983558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II).
    Squitti R; Siotto M; Cassetta E; El Idrissi IG; Colabufo NA
    Clin Chem Lab Med; 2017 Aug; 55(9):1360-1367. PubMed ID: 28076308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
    Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
    J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
    Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
    Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
    Squitti R; Ventriglia M; Gennarelli M; Colabufo NA; El Idrissi IG; Bucossi S; Mariani S; Rongioletti M; Zanetti O; Congiu C; Rossini PM; Bonvicini C
    Mol Neurobiol; 2017 Jan; 54(1):671-681. PubMed ID: 26758278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
    Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
    J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
    Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
    J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer's Disease: A Study of EEG-Derived Brain Activity.
    Tecchio F; Vecchio F; Ventriglia M; Porcaro C; Miraglia F; Siotto M; Rossini PM; Rongioletti M; Squitti R
    Curr Alzheimer Res; 2016; 13(12):1374-1384. PubMed ID: 27335037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
    Squitti R
    J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.
    Squitti R; Ghidoni R; Siotto M; Ventriglia M; Benussi L; Paterlini A; Magri M; Binetti G; Cassetta E; Caprara D; Vernieri F; Rossini PM; Pasqualetti P
    Ann Neurol; 2014 Apr; 75(4):574-80. PubMed ID: 24623259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum copper, zinc, and iron levels, and markers of carbohydrate metabolism in postmenopausal women with prediabetes and type 2 diabetes mellitus.
    Skalnaya MG; Skalny AV; Tinkov AA
    J Trace Elem Med Biol; 2017 Sep; 43():46-51. PubMed ID: 27881232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum copper profile in patients with type 1 diabetes in comparison to other metals.
    Squitti R; Negrouk V; Perera M; Llabre MM; Ricordi C; Rongioletti MCA; Mendez AJ
    J Trace Elem Med Biol; 2019 Dec; 56():156-161. PubMed ID: 31472477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer's Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an
    Squitti R; Catalli C; Gigante L; Marianetti M; Rosari M; Mariani S; Bucossi S; Mastromoro G; Ventriglia M; Simonelli I; Tondolo V; Singh P; Kumar A; Pal A; Rongioletti M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
    Ahmed AS; Elgharabawy RM; Al-Najjar AH
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function.
    Squitti R; Ventriglia M; Barbati G; Cassetta E; Ferreri F; Dal Forno G; Ramires S; Zappasodi F; Rossini PM
    J Neural Transm (Vienna); 2007; 114(12):1589-94. PubMed ID: 17641816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper in Glucose Intolerance, Cognitive Decline, and Alzheimer Disease.
    Squitti R; Mendez A; Ricordi C; Siotto M; Goldberg R
    Alzheimer Dis Assoc Disord; 2019; 33(1):77-85. PubMed ID: 30640257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
    J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
    Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
    Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies.
    Bucossi S; Ventriglia M; Panetta V; Salustri C; Pasqualetti P; Mariani S; Siotto M; Rossini PM; Squitti R
    J Alzheimers Dis; 2011; 24(1):175-85. PubMed ID: 21187586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease.
    Zappasodi F; Salustri C; Babiloni C; Cassetta E; Del Percio C; Ercolani M; Rossini PM; Squitti R
    Brain Res; 2008 Jun; 1215():183-9. PubMed ID: 18486114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.